Ortin Global Limited (BOM:539287)

India · Delayed Price · Currency is INR

17.00

+0.52 (3.16%)

At close: Jul 8, 2026

49.25% (1Y)

Market Cap	138.23M +32.1%
Revenue (ttm)	1.01M -70.7%
Net Income	-7.40M
EPS	-0.91
Shares Out	8.13M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	54
Open	17.30
Previous Close	16.48
Day's Range	17.00 - 17.30
52-Week Range	11.05 - 21.15
Beta	0.46
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Ortin Global

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulceran... [Read more]

Industry Pharmaceutical Preparations

Founded 1986

Employees 3

Stock Exchange Bombay Stock Exchange

Ticker Symbol 539287

Full Company Profile

Financial Performance

In fiscal year 2026, Ortin Global's revenue was 1.01 million, a decrease of -70.66% compared to the previous year's 3.43 million. Losses were -7.40 million, -12.52% less than in 2025.

Financial Statements